Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. (2015)

First Author: Denning E

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/hiv.12230

PubMed Identifier: 25711320

Publication URI: http://europepmc.org/abstract/MED/25711320

Type: Journal Article/Review

Volume: 16 Suppl 1

Parent Publication: HIV medicine

Issue: 0 1

ISSN: 1464-2662